| ASSET | YEAR | % RETURN |
|---|---|---|
Abbott Laboratories (ABT) | 1999 | -25.27% |
Eli Lilly and (LLY) | 1999 | -22.83% |
Berkshire Hathaway (BRK.B) | 1999 | -22.26% |
Berkshire Hathaway (BRK.A) | 1999 | -20.31% |
Bank of America (BAC) | 1999 | -13.46% |
Thermo Fisher Scientific (TMO) | 1999 | -12.73% |
Coca-Cola (KO) | 1999 | -12.16% |
PepsiCo (PEP) | 1999 | -11.93% |
Royal Bank of Canada (RY) | 1999 | -9.58% |
Merck (MRK) | 1999 | -8.19% |
AstraZeneca PLC ADR (AZN) | 1999 | -5.26% |
Novo Nordisk A-S (NVO) | 1999 | -4.52% |
Caterpillar (CAT) | 1999 | -1.82% |
Advanced Micro Devices (AMD) | 1999 | -0.22% |
Wells Fargo (WFC) | 1999 | 3.23% |
McDonald’s (MCD) | 1999 | 4.69% |
Chevron (CVX) | 1999 | 7.19% |
Exxon Mobil (XOM) | 1999 | 10.74% |
JPMorgan Chase (JPM) | 1999 | 12.5% |
Johnson & Johnson (JNJ) | 1999 | 13.75% |
HSBC Holdings PLC ADR (HSBC) | 1999 | 16.16% |
International Business Machines (IBM) | 1999 | 17.18% |
Raytheon Technologies (RTX) | 1999 | 20.41% |
UnitedHealth (UNH) | 1999 | 21.5% |
Procter & Gamble (PG) | 1999 | 23.34% |
Mega-cap stocks are treated as having a market cap of $200B+.
